Amphetamine and Dextroamphetamine Clinical Trials

• Efficacy and Safety of SPD465 in Adults with Moderately Symptomatic ADHD.
  ClinicalTrials.gov Identifier: NCT00152022 - Completed
  Attention Deficit Disorder with Hyperactivity.
  
• Safety and Efficacy of SPD465 in Adults with ADHD
  ClinicalTrials.gov Identifier: NCT00202605 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Safety of SPD465 in Treating Adults with ADHD.
  ClinicalTrials.gov Identifier: NCT00152035 - Completed
  Attention Deficit Disorder with Hyperactivity.
  
• Efficacy and Safety of SPD465 in Adults with ADHD
  ClinicalTrials.gov Identifier: NCT00150579 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Dextroamphetamine-Amphetamine Compared With Methylphenidate in Treating Children With Depression and Problems With Memory, Attention, and Thinking Caused By Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00069927 - Completed
  unspecified childhood solid tumor, protocol specific; Depression; neurotoxicity
  
• The Effects of Dextroamphetamine on Brain Function
  ClinicalTrials.gov Identifier: NCT00004556 - Recruiting
  Healthy
  
• Cognitive Correlates of Substance Abuse - 11
  ClinicalTrials.gov Identifier: NCT00000346 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Cognitive Correlates of Substance Abuse, Part 2 - 16
  ClinicalTrials.gov Identifier: NCT00000351 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Randomised Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
  ClinicalTrials.gov Identifier: NCT00123370 - Active, not recruiting
  Amphetamine Dependence
  
• To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline. - 1
  ClinicalTrials.gov Identifier: NCT00100074 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
  ClinicalTrials.gov Identifier: NCT00000350 - Active, not recruiting
  Amphetamine-Related Disorders; Tobacco Use Disorder
  
• Assessment of Potential Interactions between Methamphetamine and Bupropion - 1
  ClinicalTrials.gov Identifier: NCT00040040 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Assessment of Potential Interactions between Methamphetamine and Selegiline - 1
  ClinicalTrials.gov Identifier: NCT00033072 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Bupropion for the Treatment of Methamphetamine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00069251 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Ondansetron for the Treatment of Methamphetamine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00040053 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Assessment of Interactions between Methamphetamine and Aripiprazole - 1
  ClinicalTrials.gov Identifier: NCT00089440 - Active, not recruiting
  Amphetamine-Related Disorders
  
• A Pilot Study of Citicoline Add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
  ClinicalTrials.gov Identifier: NCT00377299 - Recruiting
  Amphetamine Abuse; Amphetamine Dependence; Bipolar Disorder; Major Depressive Disorder
  
• Amphetamine Cocaine Interaction Study - 2
  ClinicalTrials.gov Identifier: NCT00000305 - Completed
  Cocaine-Related Disorders
  
• Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1
  ClinicalTrials.gov Identifier: NCT00265278 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Tranylcypromine, Tranylcypromine Plus Dextroamphetamine and Tranylcypromine Plus Triiodothyronine as Treatment for Refractory Depression.
  ClinicalTrials.gov Identifier: NCT00296686 - Active, not recruiting
  Major Depression
  
• A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
  ClinicalTrials.gov Identifier: NCT00267657 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD
  ClinicalTrials.gov Identifier: NCT00363298 - Recruiting
  Obsessive-Compulsive Disorder
  
• Long-Term Behavior Change - 1
  ClinicalTrials.gov Identifier: NCT00158197 - Recruiting
  Adherence; Amphetamine-Related Disorders; Behavior Therapy; Contingency management; Drug Counseling; health behaviors; methamphetamine; ...
  
• Dextroamphetamine-Cocaine Behavioral Intervention - 5
  ClinicalTrials.gov Identifier: NCT00000308 - Completed
  Cocaine-Related Disorders
  
• Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients with Mood Disorders
  ClinicalTrials.gov Identifier: NCT00097175 - Recruiting
  Depressive Disorder, Major
  
• Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
  ClinicalTrials.gov Identifier: NCT00218348 - Recruiting
  Cocaine-Related Disorders
  
• Tyrosine for Methamphetamine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00000322 - Completed
  Amphetamine-Related Disorders
  
• Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
  ClinicalTrials.gov Identifier: NCT00000306 - Completed
  Cocaine-Related Disorders; Opioid-Related Disorders
  
• Brain Function in Response to Motivational Stimuli
  ClinicalTrials.gov Identifier: NCT00047866 - Recruiting
  Drug Dependence
  
• Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00514202 - Recruiting
  Attention Deficit Disorder With Hyperactivity; Cocaine-Related Disorders; Substance-Related Disorders
  
• Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
  ClinicalTrials.gov Identifier: NCT00000304 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
  ClinicalTrials.gov Identifier: NCT00227123 - Recruiting
  Bipolar Disorder; Cocaine Dependence; Amphetamine Dependence
  
• Effects of Sustained Release d-Amphetamine and Buprenorphine on Drug Seeking Behavior in Opioid and Cocaine Dependent Individuals Who Are Not Seeking Treatment
  ClinicalTrials.gov Identifier: NCT00429767 - Recruiting
  Heroin Dependence; Opioid-Related Disorders; Cocaine Abuse or Dependence
  
• Free Treatment for Cocaine Dependence: A Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00421603 - Recruiting
  Cocaine Dependence
  
• Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00553319 - Recruiting
  Adult Attention Deficit Hyperactivity Disorder; Cocaine Dependence
  
• ADDERALL XR (Mixed Salts of a Single-Entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD
  ClinicalTrials.gov Identifier: NCT00557960 - Completed
  Attention Deficit Disorder With Hyperactivity
  
• Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy
  ClinicalTrials.gov Identifier: NCT00001783 - Completed
  Cerebrovascular Accident; Paralysis
  
• Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
  ClinicalTrials.gov Identifier: NCT00247572 - Completed
  Attention Deficit Disorder With Hyperactivity; Amphetamine-Related Disorders; Substance-Related Disorders
  
• Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse
  ClinicalTrials.gov Identifier: NCT00248092 - Completed
  Attention Deficit Disorder With Hyperactivity; Amphetamine-Related Disorders; Substance-Related Disorders